tiprankstipranks
InMed Pharmaceuticals (INM)
NASDAQ:INM
US Market
Holding INM?
Track your performance easily

InMed Pharmaceuticals (INM) Financial Statements

334 Followers

InMed Pharmaceuticals Financial Overview

InMed Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-14.342; its P/E ratio is ―; InMed Pharmaceuticals is scheduled to report earnings on February 18, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 1.26M$ 1.28M$ 1.17M$ 1.24M$ 901.86K
Gross Profit$ 493.41K$ 466.07K$ 289.46K$ 324.14K$ 21.24K
EBIT$ -1.68M$ -1.93M$ -1.72M$ -1.48M$ -2.54M
EBITDA$ -1.53M$ -1.78M$ -1.57M$ -1.33M$ -2.39M
Net Income Common Stockholders$ -1.68M$ -1.94M$ -1.72M$ -1.48M$ -2.54M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 5.63M$ 6.61M$ 7.64M$ 9.58M$ 6.78M
Total Assets$ 10.47M$ 11.82M$ 13.36M$ 15.26M$ 10.92M
Total Debt$ 1.06M$ 962.66K$ 1.07M$ 1.17M$ ―
Net Debt$ -4.57M$ -5.65M$ -6.57M$ -8.41M$ ―
Total Liabilities$ 2.07M$ 2.62M$ 2.25M$ 2.48M$ 1.34M
Stockholders Equity$ 8.40M$ 9.21M$ 11.10M$ 12.77M$ 9.58M
Cash Flow-
Free Cash Flow-$ -1.03M---
Operating Cash Flow$ -1.83M$ -1.03M$ -1.93M$ -1.85M$ -2.17M
Investing Cash Flow--$ -2.00$ -9.29K-
Financing Cash Flow$ 838.24K$ 176.00-$ 4.65M-
Currency in USD

InMed Pharmaceuticals Earnings and Revenue History

InMed Pharmaceuticals Debt to Assets

InMed Pharmaceuticals Cash Flow

InMed Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis